STAT

Read the fine print: N.J. senator sets up phony health news website to attack challenger Bob Hugin

Readers expecting journalism from the upstart HealthNewsNJ.com may be in for a surprise: It’s fake news — set up by the reelection campaign of Sen. Bob Menendez.

WASHINGTON — It has headlines and bylines, an original story 834 words long, and links to 10 articles from other outlets concerning health policy and drug pricing in New Jersey. But readers expecting journalism from the upstart HealthNewsNJ.com may be in for a surprise: It’s fake news.

In reality, it’s a campaign site run by Sen. Bob Menendez (D-N.J.), who is facing a re-election challenge from Bob Hugin, the former CEO of the pharmaceutical company Celgene

The site,

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

Related Books & Audiobooks